1-42 beta-Amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death

1-42 beta-Amyloid (A beta(1-42)) peptide is a key molecule involved in the development of Alzheimer's disease. Some of its effects are manifested at the neuronal morphological level. These morphological changes involve loss of neurites due to cytoskeleton alterations. However, the mechanism of...

Descripción completa

Detalles Bibliográficos
Autores: Manterola, L., Hernando Rodríguez, M., Ruiz Núñez, Asier, Apraiz, A., Arrizabalaga Uriarte, Oskar, Vellon, L., Alberdi Alfonso, Elena María, Cavaliere, Fabio, Lacerda, Hadriano M., Jimenez, S., Parada, Luis A., Matute Almau, Carlos José, Zugaza Gurruchaga, José Luis
Tipo de recurso: artículo
Fecha de publicación:2013
País:España
Institución:Universidad del País Vasco
Repositorio:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/11340
Acceso en línea:http://hdl.handle.net/10810/11340
Access Level:acceso abierto
Palabra clave:A beta(1-42)
neuronal death program
Rac 1 GTPase
BIOLOGICAL PSYCHIATRY
PSYCHIATRY AND MENTAL HEALTH
CELLULAR AND MOLECULAR NEUROSCIENCE
Descripción
Sumario:1-42 beta-Amyloid (A beta(1-42)) peptide is a key molecule involved in the development of Alzheimer's disease. Some of its effects are manifested at the neuronal morphological level. These morphological changes involve loss of neurites due to cytoskeleton alterations. However, the mechanism of A beta(1-42) peptide activation of the neurodegenerative program is still poorly understood. Here, A beta(1-42) peptide-induced transduction of cellular death signals through the phosphatidylinositol 3-kinase (PI3K)/phosphoinositol- dependent kinase (PDK)/novel protein kinase C (nPKC)/Rac 1 axis is described. Furthermore, pharmacological inhibition of PDK1 and nPKC activities blocks Rac 1 activation and neuronal cell death. Our results provide insights into an unsuspected connection between PDK1, nPKCs and Rac 1 in the same signal-transduction pathway and points out nPKCs and Rac 1 as potential therapeutic targets to block the toxic effects of A beta(1-42) peptide in neurons.